A clinical formulation indicated for Erectile Dysfunction. This treatment promotes increased blood flow to support physical intimacy and restore erectile function.
A PDE5 inhibitor developed to alleviate erectile dysfunction symptoms and designed to support blood flow for achieving and maintaining a firm erection.
Mechanism of Action
It inhibits the PDE5 enzyme, increasing levels of cyclic GMP. This relaxes smooth muscles in the penis, facilitating blood inflow during sexual arousal.
Route of Administration
Oral
Onset Time
30–60 minutes
Duration
4–6 hours
Contraindications
Concurrent use of nitrates, Severe heart disease, Recent heart attack, Allergy to sildenafil
Information for Penegra is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
